Lab Testing in the Private Payer Market: Geographic,
Segment and Trend Analyses


View table of contents and list of figures

If you really want to know where the private payer market is headed in specific geographic regions, you must look at the historical data — numbers that, until now, were nearly impossible to locate and track.

Lab Testing in the Private Payer Market: Geographic, Segment and Trend Analyses, now available from G2 Intelligence, is the only syndicated report that breaks down and strategically interprets key dimensions of the lab market.

Why this all-new study matters.

The private payer market is important to analyze separately from other payers as it often contributes to the majority of revenue to all types of clinical and pathology labs. Therefore, G2 Intelligence specifically focuses on outpatient laboratory testing reimbursed by private payers (also known as commercial insurers) in this report.

This unique research, examining 9 key test segments in 9 U.S. Census divisions will help you:

  • Identify and assess trends and patterns in the private payer market
  • Help your organization identify and seize opportunities in your market
  • Provide in-depth analysis, strategic insight, and discussion around:
    • Patterns in lab testing utilization and revenue over time
    • How private payers and the lab industry arrived at the current geographic marketplace map
    • How labs are influenced by, and react to, market changes (e.g. ACOs, reform, and other trends)

Inside, you’ll find a wealth of valuable data and analysis, including:

  • Key trends impacting testing dynamics, with identification of major trends impacting test volumes and revenues from 2007-2012 — with detailed geographic analysis across U.S. regions and states
  • Overviews of the private payer and national laboratory testing markets
  • Characteristics of the private payer market, including private payer market segments, national private payer lab testing market landscape, and regional landscape
  • Driver analysis, with a focus on Accountable Care Organizations (ACOs) and Testing Segment Analysis
  • Implications and Conclusions for:
    • Market landscape, retrospective and prospective
    • Accountable Care Organizations
    • Shifting burden of costs to consumers
    • Highly concentrated market share and consolidation
    • Strategic insights and summary
  • Appendix: Private Payer Lab Test Volume and Revenue by State 2010-2012

Historical trend analysis can inform business decisions for executives, managers, investors, and new entrants to lab market alike. From forecasting, and market positioning, to identifying opportunities to maximize or change marketing or sales efforts, this report is an ideal companion reference to U.S. Clinical Laboratory and Pathology Testing 2013-2015: Market Analysis, Trends, and Forecasts.

Authored by G2’s Industry Experts

Jennifer Musumeci, MS, Associate Director, Advisory Services
Musumeci draws on experience from Harris Interactive, Novartis Global Oncology, KJT Group, Cegedim Strategic Data, and Bayer Healthcare Pharmaceuticals. She earned her MS in Human Development at the University of Rochester.

L. Eleanor J. Herriman, M.D., M.B.A., Managing Director, Advisory Services
Herriman’s 15+ years of market experience spans the clinical laboratory, IVD, and strategy consulting for Bain & Company. She earned her M.D. at Baylor College of Medicine, and received an M.B.A. from Harvard Business School.

Jenny Xu, Ph.D., Director of Research
Xu joins G2 from the global consultancy, ZS Associates. Her experience also includes full service market research firm, Harris Interactive. She earned her Ph.D. with honors from the Annenberg School for Communication at the University of Southern California.

Order below or call Customer Service at 855-528-6903.

For multi-user/multi-location pricing, please contact Sokha at 855-528-6903 or via email at